Securities code: Avic Jonhon Optronic Technology Co.Ltd(002179) securities abbreviation: Avic Jonhon Optronic Technology Co.Ltd(002179) Announcement No.: 2022033 Avic Jonhon Optronic Technology Co.Ltd(002179)
First quarter report 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important content tips: 1 The board of directors, the board of supervisors, directors, supervisors and senior managers guarantee that the quarterly report is true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) declare that they guarantee the authenticity, accuracy and completeness of the financial information in the quarterly report. 3. Whether the first quarter report has been audited □ yes √ No 1. Main financial data (I) whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
Increase or decrease in the reporting period compared with the same period of the previous year
Operating income (yuan): 396649804865338631741882 17.13%
Net profit attributable to shareholders of the listed company (yuan) 7373956304662440054135 18.10%
Net profit attributable to shareholders of listed company after deducting non recurring profit and loss of 7275010929761529068224% and 18.24% (yuan)
Net cash flow from operating activities (yuan) -54978205083 -30552530314 -79.95%
Basic earnings per share (yuan / share) 0.6610 0.584113.17%
Diluted earnings per share (yuan / share) 0.6552 0.584112.17%
Weighted average return on net assets 4.77%, 6.20% - 1.43%
Increase or decrease at the end of the reporting period compared with the end of the previous year
Total assets (yuan): 27838415082992698733221285 3.15%
Owner's equity attributable to shareholders of listed companies 15928194916061492449619050 6.73% (yuan)
（2） □ amount of non recurring items and inapplicability
Unit: Yuan
Description of the amount of the project in the current reporting period
Gains and losses on disposal of non current assets (including write off department with provision for asset impairment) - 62465953
(sub) government subsidies included in current profits and losses (closely related to the company's normal business,
513618748 in line with national policies and regulations and continuously enjoyed according to certain standards, quotas or quotas
Government subsidies excluded)
Other non operating income and expenditure other than the above items 829498537
Less: income tax impact 192042129
Influence amount of minority shareholders' equity (after tax) 99155454
Total 989453749--
Details of other profit and loss items that meet the definition of non recurring profit and loss: □ applicable √ not applicable. The company does not have details of other profit and loss items that meet the definition of non recurring profit and loss. Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 - non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable the company does not define the non recurring profit and loss items listed in the explanatory announcement on Information Disclosure of companies offering securities to the public No. 1 - non recurring profit and loss as recurring profit and loss items.
（3） Changes and reasons of main accounting data and financial indicators √ applicable □ not applicable (1) balance sheet
Change range and reason of the project from March 31, 2022 to December 31, 2021
Trading financial assets 14810928409614079526410509479% due to structural deposit business during the reporting period
Accounts receivable Lionco Pharmaceutical Group Co.Ltd(603669) 254019432902857309 39.45% due to the increase of operating income during the reporting period
Prepayment 97468448805433588254 79.38% due to the increase of prepayment for materials
Other receivables 44783311552382147379 88.00% increase in project deposit, current account and petty cash
Trading financial liabilities 52189189511819623894 186.81% related businesses increased during the reporting period
Other payables 5602773072680825070127 - 30.68% restricted stock incentive plan (phase II) was unlocked for the first time to reduce the repurchase obligation of other payables
Long term payables - 4723720605 - 2066670583 - 128.57% due to increased investment in scientific research projects
Treasury stock 4639972779070481163100 - 34.17% restricted stock incentive plan (phase II) was unlocked for the first time to reduce treasury stock
Other comprehensive income - 42237692 - 26447859 - 59.70% due to the increase in translation loss of foreign currency statements
(2) Income statement
Change range of the project from January to March 2022 and reasons for change from January to March 2021
Taxes and surcharges 1310213429954964393 37.20% income growth led to an increase in urban construction tax, education surcharges, stamp duty and housing buildings, resulting in an increase in real estate tax over the same period
Financial expenses 13699062 -599285379 102.29% exchange loss increased compared with the same period
Income from changes in fair value -13992065014523547 - 106341% due to changes in fair value of debt to equity swap and related businesses
Credit impairment loss 34226448569790981381 - 65.04% due to the decrease of expected credit loss of receivables
Asset impairment loss 62398029203852718442 61.96% inventory impairment loss was accrued during the reporting period
Non operating expenditure was 124637520, 188996710 - 34.05%, which was caused by the decrease in the loss from the disposal of fixed assets in the same period
2、 Shareholder information (I) total number of ordinary shareholders, number of preferred shareholders whose voting rights have been restored and shareholding of the top ten shareholders
Unit: shares
Total number of common shareholders at the end of the reporting period: 42778
Total number of prior shareholders (if any)
Shareholding of top 10 shareholders
Shareholder name shareholder nature shareholding proportion shareholding quantity holding Limited sales note pledge, marking or freezing
Number of shares in a piece number of shares in a state
China Aviation Technology
2093706% state-owned industrial legal person limited by shares
company
State owned legal person of Henan investment group 8.94% 101476112
China China Construction Bank Corporation(601939) Co., Ltd
- e fund defense other 1.60% 18212903
Military industrial hybrid securities investment fund
China's air-to-air missile state-owned legal person 1.50% 17016397
National civil Military Integration Research Institute
State owned legal person of industrial investment fund 0.74%
